Illegal internet drugs pharmacy busted in Delhi, 4 held

New Delhi: An illegal internet pharmacy, allegedly shipping drugs to overseas locations like the US and Canada, based in Delhi has been busted by the NCB with the apprehension of four people and seizure of over 41,000 psychotropic tablet strips, a senior official today said. He said the pharmacy was based in west Patel Nagar area of the national capital and was allegedly sending these drugs under the garb of auto parts and religious items.

The courier consignment bound for the US and Canada, containing 41,005 psychotropic tablet strips and over 2.4 kgs of loose tablets, has been seized as part of the operation, he said.

Four people have been apprehended till now, the official added.

“This international network had established their contacts for supply of illegal medicines in cities like Lucknow, Gurgaon, Patna, Varanasi, Mumbai and few other cities.

“All the medicines are narcotic and psychotropic substances and the operators of the online store had no valid license or document to conduct business,” Narcotics Control Bureau (NCB) Zonal Director Madho Singh said.

He said the operators were also sending spurious medicines to their customers.

“They used to parcel out these consignments through various courier companies without declaring the actual content of the parcels. We are trying to nab other members of the syndicate and further investigation is being carried out,” he said.

  • Related Posts

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval…

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Ajanta Pharma said the United States Food and Drug Administration (USFDA) has completed an inspection at its Paithan manufacturing facility in Maharashtra, conducted between 13 April and 21 April 2026.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Boehringer Ingelheim launches AI centre for pharma research in London

    Boehringer Ingelheim launches AI centre for pharma research in London

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

    Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March